#Merck

All articles tagged with "Merck"

FDA clears Merck’s once-daily two-drug HIV tablet for adults with suppressed virus

The FDA has approved Merck’s Idvynso, a once-daily two-drug tablet for certain adults with HIV-1, adding a new oral option for people who are already virologically suppressed.

Key Takeaways

The FDA approved Idvynso for adults with HIV-1 who are already virologically suppressed.
The once-daily tablet combines doravirine and islatravir in a single pill.

DT Editorial Team·May 2, 2026·via medicalxpress.com

Why Moderna and Merck Are Avoiding the Word ‘Vaccine’ for a Promising Cancer Shot

Moderna and Merck are describing a personalized mRNA cancer treatment as a therapy rather than a vaccine, reflecting how politics and regulation are reshaping biotech language.

Key Takeaways

Moderna and Merck are avoiding the word vaccine for a personalized cancer shot.
The treatment uses mRNA to train the immune system against tumor neoantigens.

DT Editorial Team·Apr 10, 2026·via technologyreview.com

Merck Eyes Lower Winrevair Dose for Rare Heart Failure Trial After Strong Early Signal

Merck says it is leaning toward a lower Winrevair dose in a planned Phase 3 study for an uncommon form of heart failure after seeing what its chief medical officer called a profound benefit at the lowest dose tested in a

Key Takeaways

Merck is planning a pivotal Winrevair trial in an uncommon heart-failure setting.
The company is leaning toward a lower dose for Phase 3.

DT Editorial Team·Mar 29, 2026·via endpoints.news